EYEG - EyeGate Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue1,652.52407.518669.259-
Cost of Revenue8,055.76310,330.3498,422.5422,717.11
Gross Profit-6,403.243-9,922.831-7,753.283-2,717.11
Operating Expenses
Research Development----
Selling General and Administrative4,441.4584,545.3545,593.5633,960.498
Non Recurring----
Others----
Total Operating Expenses12,497.22114,875.70314,016.1056,677.608
Operating Income or Loss-10,844.701-14,468.185-13,346.846-6,677.608
Income from Continuing Operations
Total Other Income/Expenses Net119.323-91.7053.409-1,710.364
Earnings Before Interest and Taxes-10,844.701-14,468.185-13,346.846-6,677.608
Interest Expense-1.04-1.215-0.275-1,934.493
Income Before Tax-10,725.378-14,559.89-13,343.437-8,387.972
Income Tax Expense86.045-1,341.973--
Minority Interest----
Net Income From Continuing Ops-10,811.423-13,217.917-13,343.437-8,387.972
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-10,811.423-13,217.917-13,343.437-8,393.149
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-10,811.423-13,217.917-13,343.437-16,615.157